Form EFFECT LENZ Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 8, 2025 |
| Accession Number: | 0001628280-25-016815 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BREAKING NEWS: ELEKTROS Builds Positive Momentum as Lithium, Critical Minerals and Proprietary EV Charging Innovation Capture Growing Investor Attention
- GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
- Ruvi AI Surpasses 60% of Phase 4 as AI Crypto Presale Continues Rapid Momentum Following Record-Breaking Phase 3
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
